Phase‑Gated Formulation Design for Poorly Soluble Active Pharmaceutical Ingredients: End‑to‑End Contract Research, Development and Manufacturing Organization from Screening to Scale‑Up
Partner Presentation Speaker: M Miles, n/a – Ardena
Formulation and Delivery
9:00 AM - 10:00 AM CT
Phase‑Gated Formulation Design for Poorly Soluble Active Pharmaceutical Ingredients: End‑to‑End Contract Research, Development and Manufacturing Organization from Screening to Scale‑Up
A Novel Laboratory-Scale Pneumatic Tube System (PTS) to Assess the Impact of Hospital PTS Transportation on the Product Quality of Therapeutic Monoclonal Antibodies
Best Practices and Guidelines (2022) for Scale-Up and Tech Transfer in Freeze-Drying Based on Case Studies. Part 1: Challenges during Scale Up and Transfer
Location: Spotlight Stage A, Aisle 2500, Exhibit Hall
Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy
Location: Spotlight Stage A, Aisle 2500, Exhibit Hall
Mapping Protein Dynamics to Decode Excipient Effects in Formulation Development
Location: Stars at Night B2/B3
Rapid Fire Speaker: Anupreet Kaur, PhD (she/her/hers) – Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology & University of Maryland
Formulation and Delivery
3:15 PM - 3:30 PM CT
Considerations for Additional Strength Waivers of ANDA Oral Modified-Release Product